Search results

Skip to results

Type

TypeGuidance (134)News (24)NICE advice (12)Quality standards (1)Research recommendations (15)

Status

StatusAwaiting development (6)Discontinued (20)In development (19)Published (92)Topic prioritisation (1)

Last updated

Last updatedLast 3 months (7)Last 6 months (11)Last year (21)Last 3 years (59)

Guidance programme

Guidance programmeClinical guidelines (14)HealthTech guidance (5)Interventional procedures guidance (5)NICE guidelines (14)Technology appraisal guidance (110)

Advice programme

Advice programmeEvidence summaries (2)Medtech innovation briefings (10)

Showing 196 to 196 of 196 results for early or locally advanced breast cancer

Sort by

Pembrolizumab plus chemotherapy not recommend for triple negative breast cancer
Draft guidance published today (8 March 2022) by NICE does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer
Result type
News
Last updated
19 January 2024

Previous page
1
…
12
13
Current page 14
Page 14 of 14

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
British National Formulary for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies